Company Overview
- Headquarters
- 201 Haskins Way Suite 210, South San Francisco CA
- Website
- graphitebio.com
- Phone
- (650) 484-0886
- Employees
- 46
- Founded in
- 2020
- Industry
- BioTech/Drugs
- Stock Symbol
- NASDAQ:GRP
Financials & Stats
Revenue
$20B
Who is Graphite Bio
Graphite Bio is a clinical-stage biotechnology company driven to discover and develop cures for serious and life-threatening diseases. Founded by academic pioneers in gene editing and gene therapy, the company is headquartered in the United States. Graphite Bio's UltraHDR™ gene editing platform uses high-efficiency precision DNA repair to correct genetic mutations and replace disease-causing genes. The company's approach has the potential to transform human health by precisely "finding and replacing" any gene in the genome. Graphite Bio is advancing the development of novel conditioning regimens to expand the reach of curative therapies to more patients. The company's leadership team brings extensive experience in gene editing and gene therapy. Graphite Bio is dedicated to translating its scientific advancements into life-changing therapies for patients. Contact Graphite Bio at graphitebio.com.
Company Leadership
Graphite Bio Tech Stack
Companies Similar to Graphite Bio
Analyze industry trends and opportunities by examining competitors and companies comparable to Graphite Bio, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 20M | 39 | Roseville, MN | 2010 | |
| 20M | Jupiter Farms, FL | |||
| 20M | 83 | Richmond Hill, NH | 1979 | |
| 20M | 70 | Davis, CA | 2006 | |
| 20M | 20 | Lexington, KY |